HOME >> MEDICINE >> NEWS
Preclinical results of Geovax's AIDS vaccines demonstrate potential to protect against disease

GeoVax Labs, Inc. (OTC BB: GOVX), an Atlanta-based biotechnology company, today reported successful results from a preclinical trial using GeoVax's vaccines for the therapeutic treatment and prevention of Acquired Immunodeficiency Disease Syndrome ("AIDS") in non-human primates. The data demonstrate the effectiveness of GeoVax's DNA/MVA vaccines in controlling the Simian ("SIV") AIDS virus through immune responses raised by the vaccines. These promising results have resulted in preliminary plans to conduct human therapeutic studies utilizing GeoVax's vaccines.

In this trial, two monkeys were infected with the SIV AIDS virus and then placed on drug therapy. Thereafter, once early drug therapy had temporarily reduced virus levels, the monkeys were vaccinated with the SIV version of GeoVax's DNA/MVA vaccines. Six weeks after vaccination, drug treatment was discontinued. The SIV virus levels temporarily rose in the vaccinated individuals, but were later "controlled" (reduced to much lower levels) by immune responses raised by the vaccines.

The reduction of virus levels in the blood stream of these AIDS virus-infected non-human primates has continued for more than a year to date. Vaccination with the GeoVax DNA/MVA vaccines has curtailed the development of AIDS and its associated debilitating effects, resulting in healthy, asymptomatic individuals. The monkeys have gained weight and have not required any additional drug therapy.

"The results of this trial demonstrate the long-term promise of our vaccines in treating HIV-AIDS," said Don Hildebrand, CEO of GeoVax Labs. "Our preclinical trials, coupled with encouraging data from two ongoing human trials, help validate the science behind our vaccines and provide the impetus for accelerating the planning of Phase II human trials for our preventive vaccines."

The ability to vaccinate those already infected with the AIDS virus, thereby inhibiting the virus' progressive and de
'"/>

Contact: Melanie Nimrodi
mnimrodi@mww.com
312-546-3508
Financial Relations Board
6-Feb-2007


Page: 1 2

Related medicine news :

1. Stem cell transplantation procedure results in long-term survival for amyloidosis patients
2. GSKs Pazopanib shows positive results in patients with advanced renal cell carcinoma
3. GSKs Pazopanib shows positive results in patients with advanced RCC and ovarian cancer
4. Targeted, oral agent Enzastaurin shows favorable results
5. Childhood obesity intervention shows promising results
6. Alpharma presents positive pharmacokinetic study results
7. UCSF brain tumor vaccine trial shows promising results
8. The eyes have it -- Autism research yields surprising results
9. ACP: Residency match results for internal medicine underscore need to redesign primary care
10. Positive results more likely from industry-funded breast cancer trials
11. Leading advocates express support for microbicide research, despite disappointing trial results

Post Your Comments:
(Date:3/5/2015)... 2015 Wimbledon Health Partners , ... echocardiogram and NCV testing, announced the addition ... Medical Officer. Dr. Artel will be responsible for medical ... WimbledonMED program and the continued growth and support of ... with Wimbledon Health Partners as a consulting physician since ...
(Date:3/5/2015)... The recent influx of online diet pills ... more and more internet ads offering “prescription” online diet ... easy for more people to fall prey to gimmicks ... their health. The company urges consumers to ask themselves ... , 1.    Where are the products manufactured and are they ...
(Date:3/5/2015)... T.E.N., a technology and information security ... winners Thursday evening, March 4, at the 2015 ... the Westin Buckhead in Atlanta, GA. , ... selected as the Information Security Executive® of the ... Pete is an industry veteran with over 15 ...
(Date:3/5/2015)... Considering egg freezing? Atlanta Center for ... an informational event on March 30, where ... families with egg freezing. , What: Egg Freezing Cocktail ... Atlanta, GA, Time: 5:30 - 7:30 PM, Date: Monday, ... here ! , In response to the growing ...
(Date:3/5/2015)... What makes a legend? In the case of renowned ... of exceptional courtroom performance, championing big causes and underdogs alike ... brilliant service, the Dallas Bar Association has named Schmidt a ... at a luncheon on Tuesday, April 7, 2015 at 12 ... nominees for this year are Bob Vial, Deborah Hankinson and ...
Breaking Medicine News(10 mins):Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 2Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 3Health News:Diet Doc Announces Four Simple Questions that Dieters Must Ask Prior to Purchasing Online Diet Pills 2Health News:Diet Doc Announces Four Simple Questions that Dieters Must Ask Prior to Purchasing Online Diet Pills 3Health News:Pete Chronis of EarthLink and Jabil Claim Top Awards at ISE® Southeast 2Health News:Pete Chronis of EarthLink and Jabil Claim Top Awards at ISE® Southeast 3Health News:Pete Chronis of EarthLink and Jabil Claim Top Awards at ISE® Southeast 4Health News:Egg Freezing Seminar Allows Women to Pause the Biological Clock for Age, Social or Medical Reasons 2Health News:Egg Freezing Seminar Allows Women to Pause the Biological Clock for Age, Social or Medical Reasons 3Health News:C.L. Mike Schmidt Named "Legend In Trial Law" by Dallas Bar Association 2
(Date:3/5/2015)... , March 5, 2015  Medical Diagnostic Laboratories, ... in high complexity, state-of-the-art, automated DNA-based molecular analyses, ... Papillomavirus (HPV) testing which utilizes cutting edge technology, ... Each year, approximately 12,000 women are diagnosed with ... . Genital Human Papillomaviruses (HPV) are a ...
(Date:3/5/2015)...  AMRI (NASDAQ: AMRI ) announced today ... position of VP of International Sales, effective immediately. He ... of Global Sales and Marketing. In ... team in an effort to increase worldwide customer value ... Pettersson will drive strategy for sales and marketing efforts ...
(Date:3/5/2015)... March 5, 2015 LUNGevity Foundation, the ... and Drug Administration,s (FDA) approval of Bristol Myers ... other immunotherapy treatments add another critical new treatment ... power of a patient,s own immune system to ... approved specifically for patients with squamous cell lung ...
Breaking Medicine Technology:Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3AMRI Hires VP of International Sales 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3
Cached News: